GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AstraZeneca PLC (OSTO:AZN) » Definitions » Shiller PE Ratio

AstraZeneca (OSTO:AZN) Shiller PE Ratio : 66.73 (As of May. 12, 2024)


View and export this data going back to 1999. Start your Free Trial

What is AstraZeneca Shiller PE Ratio?

As of today (2024-05-12), AstraZeneca's current share price is kr1679.50. AstraZeneca's E10 for the quarter that ended in Mar. 2024 was kr25.17. AstraZeneca's Shiller PE Ratio for today is 66.73.

The historical rank and industry rank for AstraZeneca's Shiller PE Ratio or its related term are showing as below:

OSTO:AZN' s Shiller PE Ratio Range Over the Past 10 Years
Min: 4.62   Med: 23.7   Max: 75.22
Current: 66.95

During the past years, AstraZeneca's highest Shiller PE Ratio was 75.22. The lowest was 4.62. And the median was 23.70.

OSTO:AZN's Shiller PE Ratio is ranked worse than
85.85% of 530 companies
in the Drug Manufacturers industry
Industry Median: 25.165 vs OSTO:AZN: 66.95

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

AstraZeneca's adjusted earnings per share data for the three months ended in Mar. 2024 was kr14.576. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is kr25.17 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


AstraZeneca Shiller PE Ratio Historical Data

The historical data trend for AstraZeneca's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AstraZeneca Shiller PE Ratio Chart

AstraZeneca Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.82 35.15 52.72 71.22 59.93

AstraZeneca Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.34 66.74 65.79 59.93 57.80

Competitive Comparison of AstraZeneca's Shiller PE Ratio

For the Drug Manufacturers - General subindustry, AstraZeneca's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AstraZeneca's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, AstraZeneca's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where AstraZeneca's Shiller PE Ratio falls into.



AstraZeneca Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

AstraZeneca's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=1679.50/25.17
=66.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AstraZeneca's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, AstraZeneca's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=14.576/130.0000*130.0000
=14.576

Current CPI (Mar. 2024) = 130.0000.

AstraZeneca Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 4.212 99.800 5.487
201409 1.426 100.000 1.854
201412 -1.907 99.900 -2.482
201503 3.760 99.600 4.908
201506 4.546 100.100 5.904
201509 5.020 100.200 6.513
201512 5.351 100.400 6.929
201603 4.253 100.400 5.507
201606 -0.020 101.000 -0.026
201609 6.825 101.500 8.741
201612 13.350 102.200 16.981
201703 3.744 102.700 4.739
201706 3.298 103.500 4.142
201709 4.325 104.300 5.391
201712 8.644 105.000 10.702
201803 2.225 105.100 2.752
201806 2.376 105.900 2.917
201809 3.039 106.600 3.706
201812 7.405 107.100 8.988
201903 4.368 107.000 5.307
201906 0.847 107.900 1.020
201909 2.233 108.400 2.678
201912 2.264 108.500 2.713
202003 5.808 108.600 6.952
202006 5.400 108.800 6.452
202009 4.339 109.200 5.165
202012 6.523 109.400 7.751
202103 10.081 109.700 11.946
202106 3.527 111.400 4.116
202109 -9.508 112.400 -10.997
202112 -2.000 114.700 -2.267
202203 2.391 116.500 2.668
202206 2.308 120.500 2.490
202209 11.456 122.300 12.177
202212 6.019 125.300 6.245
202303 12.153 126.800 12.460
202306 12.600 129.400 12.658
202309 9.755 130.100 9.748
202312 6.360 130.000 6.360
202403 14.576 130.000 14.576

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


AstraZeneca  (OSTO:AZN) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


AstraZeneca Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of AstraZeneca's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AstraZeneca (OSTO:AZN) Business Description

Address
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, immunology and rare diseases. The majority of sales come from international markets with the United States representing close to one third of its revenue.

AstraZeneca (OSTO:AZN) Headlines

From GuruFocus

AstraZeneca: Growth Is Still a Better Choice

By Nathan Aisenstadt 11-15-2023